ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1,5,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2,1,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
3,2,Myopathy,Myopathies,Muscle disorders,Musc,N
4,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
4,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
4,3,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
5,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
5,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
7,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7,2,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
8,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
8,3,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
9,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
9,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
10,1,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
11,2,Bronchitis chronic,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
11,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
11,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
12,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
13,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
13,2,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
14,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
14,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
14,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
14,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
15,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
15,2,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
15,3,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
16,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
17,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
17,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
18,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
19,2,Hyperammonaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
20,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
20,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
20,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
21,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
22,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
22,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
22,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
23,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
24,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
24,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
24,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
24,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
25,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,Y
25,2,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
25,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
26,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
26,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
26,4,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
26,5,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
26,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
26,7,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
26,8,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
27,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
27,3,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
27,4,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
28,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
28,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
28,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
28,4,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
29,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
29,2,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
30,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
30,2,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
30,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
30,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
30,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
30,6,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,Y
30,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
30,8,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
30,9,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
30,10,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
30,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
31,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,2,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
32,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
33,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
34,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
34,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
35,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
36,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
37,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
37,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
38,1,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
38,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
38,3,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
39,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
40,1,Gastroenteritis rotavirus,Rotaviral infections,Viral infectious disorders,Infec,N
40,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
41,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
42,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
42,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
42,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
42,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
43,1,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
44,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
44,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
44,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
45,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
46,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
47,1,Infertility male,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
48,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
49,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
49,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
50,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
50,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
51,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
52,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
52,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
52,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
53,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
53,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
55,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
56,1,Acne,Acnes,Skin appendage conditions,Skin,N
56,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
56,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
56,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
57,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
58,1,Acne,Acnes,Skin appendage conditions,Skin,N
58,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
59,1,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
60,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
61,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
61,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
62,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
63,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
63,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
63,3,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
63,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
64,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
64,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
64,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
65,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
67,1,Bacterial disease carrier,Infectious disorders carrier,Ancillary infectious topics,Infec,N
67,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
67,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
67,4,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
67,5,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
67,6,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
67,7,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
67,8,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
67,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
67,10,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
67,11,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
67,12,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
67,13,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
67,14,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
68,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
69,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
69,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
69,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
69,4,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
69,5,Laryngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
69,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
69,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
69,8,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
69,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
69,10,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
69,11,Tonsillar disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
69,12,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
70,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
70,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
70,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
70,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
70,5,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
71,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
72,1,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
73,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
74,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
74,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
75,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
76,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
77,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
77,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
77,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
78,1,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
79,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
79,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
79,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
79,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
80,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
81,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,Y
81,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
81,3,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
82,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
82,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
82,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
82,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
83,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
83,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
84,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
85,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
86,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
86,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
86,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
86,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
87,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
88,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
88,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
89,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
89,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
89,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
89,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
89,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
89,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
90,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
90,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
90,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
90,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
91,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
91,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
92,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
93,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
93,2,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
94,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
94,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
95,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
96,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
96,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
96,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
97,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
98,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
99,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
99,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
99,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
99,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
99,5,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
99,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
100,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
101,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
102,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
102,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
102,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
102,4,Computerised tomogram abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
102,5,Coronary artery stenosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
102,6,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
102,7,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
102,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
102,9,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
102,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
102,11,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
102,12,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
102,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
102,14,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
102,15,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
102,16,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
102,17,Vascular graft complication,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
103,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
103,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
103,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
103,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
103,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
104,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
104,2,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
105,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
106,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
106,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
107,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
107,2,Haemorrhagic disorder,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
107,3,Haemorrhagic infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
107,4,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
107,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
107,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
107,7,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
107,8,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
108,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
109,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
110,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
110,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
111,1,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
111,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
112,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
112,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
113,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
114,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
114,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
114,3,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
115,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
116,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
117,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
117,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
117,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
118,1,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
119,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
120,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
120,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
120,3,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
120,4,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
121,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
121,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
121,3,Pneumonia staphylococcal,Staphylococcal infections,Bacterial infectious disorders,Infec,Y
122,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
122,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
123,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
123,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
123,3,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
123,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
123,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
123,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
124,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
125,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
125,2,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
125,3,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
126,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
127,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
128,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
129,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
130,1,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
130,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
130,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
131,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
131,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
131,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
131,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
132,1,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
133,1,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
133,2,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
133,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
133,4,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
133,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
134,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
135,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
136,1,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
136,2,Ovarian dysgerminoma stage unspecified,Ovarian germ cell neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
136,3,Splenic lesion,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
137,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
137,2,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
138,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
139,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
140,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
141,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
142,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
142,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
142,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
142,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
143,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
144,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
144,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
145,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
145,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
146,1,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
147,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
148,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
148,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
148,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
149,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
150,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
151,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
152,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
152,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
152,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
153,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
153,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
153,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
153,4,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
154,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
155,1,Acne,Acnes,Skin appendage conditions,Skin,N
155,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
155,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
155,4,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
156,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
156,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
157,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
158,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
159,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
160,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
160,2,Blood immunoglobulin E increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
160,3,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
160,4,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
160,5,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
160,6,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
160,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
160,8,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
160,9,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
160,10,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
160,11,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
160,12,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
160,13,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
160,14,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
160,15,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
160,16,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
160,17,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
160,18,Myopathy,Myopathies,Muscle disorders,Musc,N
160,19,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
160,20,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
160,21,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
160,22,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
160,23,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
160,24,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
160,25,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
160,26,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
160,27,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
160,28,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
161,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
161,2,Catheter removal,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
161,3,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
161,4,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
161,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
161,6,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
161,7,Red blood cell schistocytes present,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
161,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
161,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
161,10,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
162,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
163,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
164,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
165,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
166,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
167,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
168,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
169,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
170,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
171,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
172,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
172,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
172,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
172,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
173,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
174,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
175,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
176,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
177,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
177,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
177,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
177,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
178,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
178,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
178,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
179,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
179,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
179,3,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
180,1,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
181,1,Bone marrow oedema,Haematological disorders,Haematological disorders NEC,Blood,N
182,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
182,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
182,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
183,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
184,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
185,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
186,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
186,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
186,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
187,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
187,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
187,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
188,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
189,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
189,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
190,1,Oral fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
191,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
191,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
191,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
192,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
192,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
193,1,Intestinal operation,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
194,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
194,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
194,3,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
195,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
195,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
195,3,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
195,4,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
195,5,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
195,6,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
196,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
197,1,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
198,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
198,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
199,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
200,1,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
200,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
200,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
200,4,Non-cardiogenic pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
200,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
200,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
201,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
201,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
201,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
202,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
203,1,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
204,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
204,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
205,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
205,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
206,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
206,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
206,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
207,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
207,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
207,3,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
207,4,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
208,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
208,2,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
209,1,Headache,Headaches NEC,Headaches,Nerv,N
209,2,Seizure cluster,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
210,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
210,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
211,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
211,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
211,3,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
211,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
211,5,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
211,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
211,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
211,8,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
212,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
212,2,Anastomotic ulcer,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
212,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
212,4,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
212,5,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
212,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
212,7,Norovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
212,8,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
212,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
212,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
212,11,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
212,12,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
212,13,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
213,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
213,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
213,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
214,1,Hand dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
215,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
215,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
216,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
217,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
218,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
218,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
219,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
220,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
221,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
222,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
222,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
222,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
222,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
223,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
224,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
225,1,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
226,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
227,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
228,1,Asbestosis,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
228,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
229,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
230,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
231,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
231,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
231,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
232,1,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
233,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
234,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
235,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
236,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
237,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
238,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
239,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
239,2,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
240,1,Chordoma,Bone neoplasms unspecified malignancy,Skeletal neoplasms malignant and unspecified,Neopl,N
240,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
240,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
240,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
241,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
242,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
242,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
243,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
243,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
244,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
244,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
244,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
245,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
246,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
247,1,Back injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
247,2,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
247,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
248,1,Cow pox,Orthopox viral infections,Viral infectious disorders,Infec,N
248,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
248,3,Mandibular mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
248,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
248,5,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
248,6,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
248,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
248,8,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
248,9,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
248,10,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
248,11,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
248,12,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
248,13,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
248,14,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
248,15,Tonsillar inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
248,16,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
248,17,Upper airway obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
249,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
250,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
251,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
252,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
253,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
254,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
255,1,Cow pox,Orthopox viral infections,Viral infectious disorders,Infec,N
255,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
255,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
256,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
257,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
258,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
258,2,Adjusted calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
258,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
258,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
258,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
258,6,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
258,7,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
258,8,Globulins decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
258,9,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
258,10,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
258,11,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
258,12,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
258,13,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
258,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
258,15,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
258,16,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
259,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
260,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
260,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
260,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
260,4,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
260,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
261,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
262,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
262,2,Lymphocele,Lymphangiopathies,Lymphatic vessel disorders,Vasc,N
262,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
262,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
263,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
263,2,Lymphocele,Lymphangiopathies,Lymphatic vessel disorders,Vasc,N
263,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
263,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
264,1,Jejunal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
264,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
264,3,Skin squamous cell carcinoma metastatic,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,Y
265,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
265,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
265,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
265,4,Hypertrichosis,Hypertrichoses,Skin appendage conditions,Skin,N
265,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
266,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
266,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
266,3,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
266,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
267,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
267,2,Glassy eyes,General signs and symptoms NEC,General system disorders NEC,Genrl,N
267,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
267,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
268,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
268,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
268,3,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
268,4,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
268,5,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
269,1,Necrotising enterocolitis neonatal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,Y
269,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
270,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
270,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
270,3,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
270,4,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
271,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
272,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
272,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
272,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
273,1,Fibrosarcoma,Fibrosarcomas malignant,Soft tissue neoplasms malignant and unspecified,Neopl,N
274,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
274,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
275,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
275,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
276,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
276,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
276,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
277,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
277,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
277,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
277,4,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
278,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
278,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
278,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
278,4,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
279,1,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
280,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
280,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
280,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
281,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
281,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
281,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
281,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
281,5,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
281,6,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
282,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
282,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
282,3,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
283,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
283,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
284,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
285,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
285,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,Y
285,3,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
285,4,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
285,5,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
286,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
286,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
286,3,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,Y
286,4,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
286,5,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
286,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
286,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
287,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
287,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
288,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
288,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
288,3,Gastrointestinal wall thickening,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
288,4,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
289,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
289,2,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
290,1,Neonatal infection,Infections NEC,Infections - pathogen unspecified,Infec,N
290,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
290,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
290,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
291,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
291,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
292,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
292,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
293,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
293,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
294,1,Bone infarction,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
295,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
295,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
295,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
295,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
295,5,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
295,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
295,7,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
295,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
295,9,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
295,10,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
295,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
295,12,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
295,13,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
295,14,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
296,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
296,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
296,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
297,1,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
297,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
298,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
299,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
299,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
299,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
299,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
299,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
299,6,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
299,7,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
299,8,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
299,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
300,1,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
300,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
301,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
301,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
302,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
303,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
303,2,Slow speech,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
304,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
304,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
304,3,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
304,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
304,5,Microvillous inclusion disease,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
304,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
305,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
306,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
307,1,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
307,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
308,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
309,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
309,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
309,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
309,4,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
310,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
311,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
311,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
312,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
312,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
313,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
313,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
314,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
314,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
315,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
316,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
317,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
318,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
318,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
319,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
320,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
320,2,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
321,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
321,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
322,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
323,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
324,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
324,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
325,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
326,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
327,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
328,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
328,2,Neutropenia neonatal,Neutropenias,White blood cell disorders,Blood,N
328,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
328,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
329,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
329,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
330,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
330,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
331,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
331,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
332,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
332,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
332,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
332,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
333,1,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
334,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
334,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
334,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
334,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
335,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
336,1,Anosognosia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
336,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
336,3,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
336,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
337,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
338,1,Anosognosia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
338,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
338,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
338,4,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
338,5,Renal vessel disorder,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
338,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
338,7,Visual pathway disorder,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
339,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
340,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
